vs

Side-by-side financial comparison of Kiniksa Pharmaceuticals International, plc (KNSA) and SentinelOne, Inc. (S). Click either name above to swap in a different company.

SentinelOne, Inc. is the larger business by last-quarter revenue ($258.9M vs $202.1M, roughly 1.3× Kiniksa Pharmaceuticals International, plc). Kiniksa Pharmaceuticals International, plc runs the higher net margin — 7.0% vs -23.3%, a 30.3% gap on every dollar of revenue. On growth, Kiniksa Pharmaceuticals International, plc posted the faster year-over-year revenue change (65.0% vs 22.9%). Kiniksa Pharmaceuticals International, plc produced more free cash flow last quarter ($53.3M vs $20.9M).

Kiniksa Pharmaceuticals International plc is a global biopharmaceutical firm focused on discovering, developing and commercializing targeted therapies for patients with unmet medical needs, primarily in autoimmune, inflammatory and rare disease segments. It operates across major markets including North America, Europe and Asia, advancing a pipeline of clinical-stage and approved treatment candidates.

SentinelOne, Inc. is an American cybersecurity company listed on NYSE based in Mountain View, California. The company was founded in 2013 by Tomer Weingarten, Almog Cohen and Ehud ("Udi") Shamir. Weingarten acts as the company's CEO. The company has approximately 2,800 employees and offices in Mountain View, Boston, Prague, Tokyo, and Tel Aviv. The company uses machine learning for monitoring personal computers, IoT devices, and cloud workloads. The company's platform utilizes a heuristic mod...

KNSA vs S — Head-to-Head

Bigger by revenue
S
S
1.3× larger
S
$258.9M
$202.1M
KNSA
Growing faster (revenue YoY)
KNSA
KNSA
+42.0% gap
KNSA
65.0%
22.9%
S
Higher net margin
KNSA
KNSA
30.3% more per $
KNSA
7.0%
-23.3%
S
More free cash flow
KNSA
KNSA
$32.4M more FCF
KNSA
$53.3M
$20.9M
S

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
KNSA
KNSA
S
S
Revenue
$202.1M
$258.9M
Net Profit
$14.2M
$-60.3M
Gross Margin
89.6%
73.8%
Operating Margin
9.8%
-28.3%
Net Margin
7.0%
-23.3%
Revenue YoY
65.0%
22.9%
Net Profit YoY
259.8%
23.1%
EPS (diluted)
$0.18
$-0.18

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
KNSA
KNSA
S
S
Q4 25
$202.1M
$258.9M
Q3 25
$180.9M
$242.2M
Q2 25
$156.8M
$229.0M
Q1 25
$137.8M
Q4 24
$122.5M
Q3 24
$112.2M
Q2 24
$108.6M
Q1 24
$79.9M
Net Profit
KNSA
KNSA
S
S
Q4 25
$14.2M
$-60.3M
Q3 25
$18.4M
$-72.0M
Q2 25
$17.8M
$-208.2M
Q1 25
$8.5M
Q4 24
$-8.9M
Q3 24
$-12.7M
Q2 24
$-3.9M
Q1 24
$-17.7M
Gross Margin
KNSA
KNSA
S
S
Q4 25
89.6%
73.8%
Q3 25
88.8%
75.0%
Q2 25
88.1%
75.3%
Q1 25
87.0%
Q4 24
85.4%
Q3 24
82.1%
Q2 24
88.7%
Q1 24
86.7%
Operating Margin
KNSA
KNSA
S
S
Q4 25
9.8%
-28.3%
Q3 25
13.3%
-33.3%
Q2 25
12.9%
-38.2%
Q1 25
9.6%
Q4 24
-15.7%
Q3 24
-8.6%
Q2 24
-0.1%
Q1 24
-20.7%
Net Margin
KNSA
KNSA
S
S
Q4 25
7.0%
-23.3%
Q3 25
10.2%
-29.7%
Q2 25
11.4%
-90.9%
Q1 25
6.2%
Q4 24
-7.3%
Q3 24
-11.3%
Q2 24
-3.6%
Q1 24
-22.2%
EPS (diluted)
KNSA
KNSA
S
S
Q4 25
$0.18
$-0.18
Q3 25
$0.23
$-0.22
Q2 25
$0.23
$-0.63
Q1 25
$0.11
Q4 24
$-0.11
Q3 24
$-0.18
Q2 24
$-0.06
Q1 24
$-0.25

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
KNSA
KNSA
S
S
Cash + ST InvestmentsLiquidity on hand
$414.1M
$649.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$567.6M
$1.5B
Total Assets
$763.6M
$2.4B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
KNSA
KNSA
S
S
Q4 25
$414.1M
$649.8M
Q3 25
$352.1M
$810.8M
Q2 25
$307.8M
$766.9M
Q1 25
$268.3M
Q4 24
$243.6M
Q3 24
$223.8M
Q2 24
$218.8M
Q1 24
$213.6M
Stockholders' Equity
KNSA
KNSA
S
S
Q4 25
$567.6M
$1.5B
Q3 25
$535.4M
$1.5B
Q2 25
$495.0M
$1.5B
Q1 25
$457.5M
Q4 24
$438.4M
Q3 24
$437.0M
Q2 24
$435.1M
Q1 24
$431.9M
Total Assets
KNSA
KNSA
S
S
Q4 25
$763.6M
$2.4B
Q3 25
$712.3M
$2.4B
Q2 25
$661.1M
$2.4B
Q1 25
$599.3M
Q4 24
$580.6M
Q3 24
$555.3M
Q2 24
$542.4M
Q1 24
$519.7M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
KNSA
KNSA
S
S
Operating Cash FlowLast quarter
$53.9M
$21.0M
Free Cash FlowOCF − Capex
$53.3M
$20.9M
FCF MarginFCF / Revenue
26.4%
8.1%
Capex IntensityCapex / Revenue
0.3%
0.0%
Cash ConversionOCF / Net Profit
3.80×
TTM Free Cash FlowTrailing 4 quarters
$136.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
KNSA
KNSA
S
S
Q4 25
$53.9M
$21.0M
Q3 25
$33.7M
$-1.0M
Q2 25
$28.1M
$52.3M
Q1 25
$22.3M
Q4 24
$18.8M
Q3 24
$-2.2M
Q2 24
$5.2M
Q1 24
$4.0M
Free Cash Flow
KNSA
KNSA
S
S
Q4 25
$53.3M
$20.9M
Q3 25
$33.0M
$-1.3M
Q2 25
$27.9M
$52.1M
Q1 25
$22.2M
Q4 24
$18.6M
Q3 24
Q2 24
Q1 24
$3.9M
FCF Margin
KNSA
KNSA
S
S
Q4 25
26.4%
8.1%
Q3 25
18.2%
-0.5%
Q2 25
17.8%
22.8%
Q1 25
16.1%
Q4 24
15.2%
Q3 24
Q2 24
Q1 24
4.9%
Capex Intensity
KNSA
KNSA
S
S
Q4 25
0.3%
0.0%
Q3 25
0.4%
0.1%
Q2 25
0.1%
0.1%
Q1 25
0.1%
Q4 24
0.2%
Q3 24
0.0%
Q2 24
0.0%
Q1 24
0.1%
Cash Conversion
KNSA
KNSA
S
S
Q4 25
3.80×
Q3 25
1.83×
Q2 25
1.58×
Q1 25
2.61×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

KNSA
KNSA

Segment breakdown not available.

S
S

US$154.8M60%
Non Us$104.1M40%

Related Comparisons